# Sorriso Pharmaceuticals, Inc. — Form D

Sorriso Pharmaceuticals, Inc. of SANDY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-11. The offering totals $31.4M, of which $21.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-01-11
- Form: D
- Accession: 0001903902-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $31.4M
- Amount sold: $21.3M
- Remaining: $10.1M
- Investors: 11
- Date of first sale: 2021-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-428887

## Issuer

- Name: Sorriso Pharmaceuticals, Inc.
- CIK: 0001903902
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6 NORTHRIDGE WAY, SANDY, UT, 84092
- Phone: (619) 733-3852

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Mark Chin | Director | Cambridge, MA |
| Michael Grey | Director | South San Francisco, CA |
| Ciara Kennedy, Ph.D. | Director | Sandy, UT |
| Edward Mathers | Director | South San Francisco, CA |
| Brian Dorsey | Executive Officer | Sandy, UT |
| Susan Dube | Executive Officer | Sandy, UT |
| Ciara Kennedy, Ph.D. | Executive Officer | Sandy, UT |

## More

- [CIK 1903902 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1903902&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001903902-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.